Inflammatory Genes and Colorectal Cancer Risk
Author Information
Author(s): Stefano Landi, Federica Gemignani, Fabio Bottari, Lydie Gioia-Patricola, Elisabet Guino, María Cambray, Sebastiano Biondo, Gabriel Capella, Laura Boldrini, Federico Canzian, Victor Moreno
Primary Institution: University of Pisa
Hypothesis
Do polymorphisms in inflammatory genes affect the risk of colorectal cancer?
Conclusion
The study found no significant association between the inflammatory gene polymorphisms and colorectal cancer risk.
Supporting Evidence
- The study analyzed ten SNPs in inflammatory genes related to colorectal cancer.
- No statistically significant associations were found between the SNPs and colorectal cancer risk.
- The study suggests that the selected inflammatory genes may not play a role in colorectal cancer.
Takeaway
The study looked at genes related to inflammation to see if they affect the chances of getting colon cancer, but they didn't find any links.
Methodology
The study involved 377 colorectal cancer cases and 326 controls, analyzing ten SNPs in various inflammatory genes.
Potential Biases
Potential selection bias was minimized by selecting incident cases and controls from the same hospital.
Limitations
The selected inflammatory genes may not be involved in colorectal cancer, or the effects of the SNPs may be too small to detect without a larger sample size.
Participant Demographics
All participants were Caucasian, with a participation rate of 72% for cases and 69.4% for controls.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website